new IV antibiotic called Zeftera (ceftobiprole) to fight methicillin-resistant Staph aureus (MRSA)

Canadians will have a new IV antibiotic called Zeftera (ceftobiprole) to fight methicillin-resistant Staph aureus (MRSA).

Zeftera is an extended-spectrum cephalosporin...some are calling it the "fifth" generation.

It has activity against gram-positive and gram-negative bacteria. But its most unique feature is that it's also effective against MRSA.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter Canada includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 300+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get quote